TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from Baseline in Parental Assessment Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite Endpoints of Cardiovascular Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with major adverse cardiac event
Endpoint domain: Adverse events/effects
Primary endpoint: Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in symptom control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Influence of pain on the quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Half-life of BIVV001
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life of SHL rFVIII
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-Life of EHL rFVIII
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in BSGM parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of adequate knowledge, attitude and practice/behaviour towards viral hepatitis B and C
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cortical lesion number accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak force of knee extensors during isometric contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Competence Scale (PCS) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Strength of lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from Baseline Muscle Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in insulin resistance measured by HOMA-IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in insulin resistance measured by QUICKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of renal flare, escalation of immunosuppressive medication, or death
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with Treatment Emergent Adverse Events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Gross Motor Function Measure 88
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of gastric adenocarcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Participants with Hematology, Clinical Chemistry, Urinalysis Laboratory Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of Participants with 12-lead electrocardiograms (ECG) Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of Participants with Vital Sign and Physical Examinations Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of procedures with adverse events related to JTIN
Endpoint domain: Adverse events/effects
Primary endpoint: Breastfeeding Self-Efficacy Scale Short Form Antenatal score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The Infant Breastfeeding Assessment Tool score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The LATCH Breastfeeding Diagnostic Tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breastfeeding Self-Efficacy Scale Short Form Postnatal score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PD-L1 tumor expression heterogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of (severe) adverse events (SAE/AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mental health help-seeking intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: internal rotation, external rotation and total range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of participants who experienced any grade of AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants who experienced any SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Pressure Algometry Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of capsules successfully recovered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale (mRS) score of 0-2
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of insomnia symptoms (bedtime resistance)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change of insomnia symptoms (sleep onset delay)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change of insomnia symptoms (night waking)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Post-transplant renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of children completing all three follow up visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Pleural Effusion Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of ICUs utilising prone positioning for ARDS patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PaO2/FiO2 threshold for starting prone positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean tidal volumes used for mild, moderate, and severe ARDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity scores for Columbia-Suicide Severity Rating Scale (C-SSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Mental health outcomes
Primary endpoint: Levels of infection indicators in Cerebrospinal fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of patients with Symptomatic intracerebral hemorrhage (ICH)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with major extracranial bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with non-bleeding adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Non-inferiority of Poppins Clinical
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of cervicovaginal cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Activated CD4+ T cells and antigen presenting cells per mg cervical biopsy tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence of cultivable Lactobacillus spp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression rate of gastric intestinal metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Progression rate of gastric intestinal metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of real-world treatment regimens
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Contraction strength in the cuff deflation phase of RIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hyperaemic myocardial blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute hospitalization rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total Medicare Parts A and B expenditures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of youths accessing community mental health resources
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Successful Neuropixels Probe Recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the PRO2 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thermal Pain Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skindex score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Kidney Disease Quality of Life Short Form (KDQOL-SF™)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Device Integrity and Functionality at 30 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SGRQ symptom component score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cervical pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cervical proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tissue sodium content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in lymphedema severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in limb extracellular water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of gastrointestinal acute GVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients who change treatment management
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post-procedure rate of gastroesophageal reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: serious postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Lip Support Changes in 3D (μm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total standardized daily dosage (TSDD) of medication classes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of knowledge and skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 3D reconstruction of lower limb parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Montreal Cognitive Assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in conversion rate from normal cognitive function (PD-N) to mild cognitive impairment (PD-MCI) and from PD-N or PD-MCI to Parkinson-Dementia (PD-D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SOFA score at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromuscular Intensity (Bicycling Cadence, Revolutions Per Minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular Intensity (Heart Rate, Beats Per Minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual Attention (Infrared Eye-tracking Data)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival of the allograft
Endpoint domain: Mortality/survival
Primary endpoint: Ventilator-free days at 60 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: breast symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Neuropathy Impairment Score (NIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Score of multiple-choice question test about fasting before operation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of participants with abnormal laboratory tests results
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Participant Retention Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participant Adherence Rate to Medically-Tailored Meals (MTM)
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Change in the number of apneas/hypopneas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Plasma glucagon concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: long-term benefit of PD-1 inhibition
Endpoint domain: Mortality/survival
Primary endpoint: Symptoms experienced by patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic swallowing MRI imaging data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Occurrence of oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Severity of Oral Mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in severity of intestinal mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: fasting and postprandial pyloric diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: fasting and postprandial pyloric distensibility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: fasting and postprandial distal antral motility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Physiological changes in pupil diameter, blood pressure, heart rate, respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygenation (PaO2/FiO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Degree of improvement in photographs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain Anxiety Symptom Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with modified Rankin Score 0-2 at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oxygen saturation (SpO2%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Adverse Drug Reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Heart Rate changes to laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure changes to laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: DNA alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: RNA alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: DNA methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Circulating tumor DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of eligible patients who agreed to participate in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of intervention delivered (Dose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of recruited participants providing data for each baseline and outcome measure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Correlation of blood samples for biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Management of adverse effects of hormonal contraception
Endpoint domain: Adverse events/effects
Primary endpoint: Intervention-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Lesion fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time on Supplemental Oxygen Support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in LVEF (Left ventricular ejection fraction) of more than 10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase >15% in the VTSVIi (The end-systolic volume of the indexed left ventricle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical evidence of HF (Heart Failure) based on global assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline oxyhemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes from baseline deoxyhemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes from baseline tissue oxygenation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of amylogenic protein in respiratory amyloidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of life grade
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to durable CTI block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of ischemic or hemorrhagic or undetermined stroke
Endpoint domain: Mortality/survival
Primary endpoint: Time to first occurrence of the composite of stroke (ischemic or hemorrhagic or undetermined), TIA and systemic embolism
Endpoint domain: Mortality/survival
Primary endpoint: Satisfaction as assessed by the Intervention Satisfaction Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of intervention Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PROMIS Ability to participate in social roles and activity
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: PROMIS Physical Function (10a)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: early behavioral evidence of neurodegeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: physiologic evidence of neurodegeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: anatomic evidence of neurodegeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: protein evidence of neurodegeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in Period Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of epileptiform activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PRINTO 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change in Weekly Urticaria Assessment Score (UAS7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of device count accuracy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: User experience about general look and feel and user satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: User perception about the confidence about the accuracy of the count
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of AI model to diagnose extensive intestinal metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum titers of total anti-Porphyromonas gingivalis (Pg) antibody (Ab)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum protease activity inhibition (PAI) titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active-matrix metalloproteinase-8 (aMMP-8) levels measured by immunoassay in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in family functioning
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Incidence of osilodrostat-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Thoracic kyphosis (T1- T12 angle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical alignment head-pelvis (angle OD-HA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical alignment head-C7 vertebra (angle OD-C7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cystitis relapses
Endpoint domain: Adverse events/effects
Primary endpoint: Participant Intervention Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Resuscitation Knowledge Test at 3 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiopulmonary Resuscitation Skills Checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digit symbol daily score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Memory daily score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of the Δ6-8 deletion of the LEPR gene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achilles tendon total rupture score (ATRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes